Table 2.
Lipid profile predictive of HCC on background of NAFLD
| Metabolite name | Coefficient |
|---|---|
| Asymmetrie dimethylarginine | 16.4728789 |
| CAR(18:0–DQ | 2.643794344 |
| CAR(26:1) | –1.115760821 |
| Cer(d16:1/24:0) | 6.636870471 |
| Cer(d18:2/24:0) | 4.846124 |
| Cer(d18:1/24:0) | 4.204558483 |
| LPC(0:0/14:0) | –4.033630203 |
| LPC(14:0/0:0) | –5.50639709 |
| LPC(15:0/0:0) | –7.825665552 |
| LPC(20:3/0:0)_1 | 1.310188498 |
| LPI(20:3/0:0) | –3.339869581 |
| PC(16:0/16:0) | 4.506361519 |
| PC(P-18:0/18:1) | 9.056127427 |
| SM(d16:1/20:0) | –3.502104041 |
| SM(d16:1/22:0) | –0.45509791 |
| SM(d16:1/24:0) | –1.614155581 |
| SM(d18:2/23:0) | –2.593395293 |
| SM(d18:2/24:0) | –4.584937325 |
| SM(d18:1/24:0) | –4.774057238 |
| SM(d18:2/22:0) | –5.331737388 |
| SM(d18:1/23:0) | –5.646288334 |
Coefficient of variance is given. PC, phosphocholine; Cer, ceramide; CAR, Fatty acyl carnitine; LPC, lysophosphocholine; SM, sphingomyelin; LPI, lysophosphatidylinositol.